Severe brain involvement in 5q spinal muscular atrophy type 0

Carregando...
Imagem de Miniatura
Citações na Scopus
28
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
ROCHA, Antonio J.
LOZANO-ARANGO, Andres
DIAZ, Astry B.
CASTIGLIONI, Claudia
PARAMONOV, Ida
CUSCO, Ivon
Citação
ANNALS OF NEUROLOGY, v.86, n.3, p.458-462, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Spinal muscular atrophy (SMA) type 0 is the most severe form of SMA, associated with the SMN1 gene and manifesting at birth. Most patients die in the first weeks of life. In this work, we present 3 patients with SMA type 0 who survived >1 year and presented diffuse and progressive brain abnormalities on magnetic resonance imaging, which are not usually seen in patients with SMA. Thus, severe brain involvement may likely be the full end manifestation of an already extreme SMA phenotype caused by substantial reduction of the SMN protein in the brain. ANN NEUROL 2019
Palavras-chave
Referências
  1. Calucho M, 2018, NEUROMUSCULAR DISORD, V28, P208, DOI 10.1016/j.nmd.2018.01.003
  2. Devriendt K, 1996, ANN NEUROL, V40, P731, DOI 10.1002/ana.410400509
  3. Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49
  4. Finkel R, 2015, NEUROMUSCULAR DISORD, V25, P593, DOI 10.1016/j.nmd.2015.04.009
  5. Grotto Sarah, 2016, J Neuromuscul Dis, V3, P487
  6. Harding BN, 2015, J NEUROPATH EXP NEUR, V74, P15, DOI 10.1097/NEN.0000000000000144
  7. Ito Y, 2004, BRAIN DEV-JPN, V26, P53, DOI 10.1016/S0387-7604(03)00075-5
  8. Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467
  9. LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
  10. Polido GJ, 2017, NEUROMUSCULAR DISORD, V27, P419, DOI 10.1016/j.nmd.2017.01.017
  11. RudnikSchoneborn S, 1996, NEUROPEDIATRICS, V27, P8, DOI 10.1055/s-2007-973741
  12. SHISHIKURA K, 1983, ACTA NEUROPATHOL, V60, P99, DOI 10.1007/BF00685353
  13. Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134
  14. Talbot K, 2017, GENE THER, V24, P529, DOI 10.1038/gt.2017.52
  15. Tizzano EF, 2017, NEUROMUSCULAR DISORD, V27, P883, DOI 10.1016/j.nmd.2017.05.011
  16. TOWFIGHI J, 1985, ACTA NEUROPATHOL, V65, P270, DOI 10.1007/BF00687008
  17. Varghese Binoj, 2016, Indian J Radiol Imaging, V26, P316
  18. von Gontard A, 2002, NEUROMUSCULAR DISORD, V12, P130, DOI 10.1016/S0960-8966(01)00274-7
  19. Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340
  20. YOHANNAN M, 1991, ACTA NEUROL SCAND, V84, P426, DOI 10.1111/j.1600-0404.1991.tb04982.x